BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 34668521)

  • 1. SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis.
    Dong B; Gao Y; Kang X; Gao H; Zhang J; Guo H; You MJ; Xue W; Cheng J; Huang Y
    Oncotarget; 2016 Dec; 7(49):80435-80449. PubMed ID: 27741516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 Expression in Clear Cell Renal Cell Carcinoma (ccRCC) Correlates with Tumor Grade and Patient Survival and Is Affected by Gene Methylation.
    Papanastasiou AD; Peroukidis S; Sirinian C; Arkoumani E; Chaniotis D; Zizi-Sermpetzoglou A
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.
    Wei X; Choudhury Y; Lim WK; Anema J; Kahnoski RJ; Lane B; Ludlow J; Takahashi M; Kanayama HO; Belldegrun A; Kim HL; Rogers C; Nicol D; Teh BT; Tan MH
    Sci Rep; 2017 Aug; 7(1):7342. PubMed ID: 28779136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.
    Hakimi AA; Reznik E; Lee CH; Creighton CJ; Brannon AR; Luna A; Aksoy BA; Liu EM; Shen R; Lee W; Chen Y; Stirdivant SM; Russo P; Chen YB; Tickoo SK; Reuter VE; Cheng EH; Sander C; Hsieh JJ
    Cancer Cell; 2016 Jan; 29(1):104-116. PubMed ID: 26766592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.
    Kubala JM; Laursen KB; Schreiner R; Williams RM; van der Mijn JC; Crowley MJ; Mongan NP; Nanus DM; Heller DA; Gudas LJ
    Cancer Biol Ther; 2023 Dec; 24(1):2170669. PubMed ID: 36722045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperpolarized
    Ursprung S; Woitek R; McLean MA; Priest AN; Crispin-Ortuzar M; Brodie CR; Gill AB; Gehrung M; Beer L; Riddick ACP; Field-Rayner J; Grist JT; Deen SS; Riemer F; Kaggie JD; Zaccagna F; Duarte JAG; Locke MJ; Frary A; Aho TF; Armitage JN; Casey R; Mendichovszky IA; Welsh SJ; Barrett T; Graves MJ; Eisen T; Mitchell TJ; Warren AY; Brindle KM; Sala E; Stewart GD; Gallagher FA
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.
    Revel M; Rezola Artero M; Hamidi H; Grunenwald A; Blasco L; Vano YA; Marie Oudard S; Sanchez-Salas R; Macek P; Rodriguez Sanchez L; Cathelineau X; Vedié B; Sautes-Fridman C; Herman Fridman W; Roumenina LT; Dragon-Durey MA
    Oncoimmunology; 2024; 13(1):2328433. PubMed ID: 38487624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary dynamics of glucose-deprived cancer cells: insights from experimentally informed mathematical modelling.
    Almeida L; Denis JA; Ferrand N; Lorenzi T; Prunet A; Sabbah M; Villa C
    J R Soc Interface; 2024 Jan; 21(210):20230587. PubMed ID: 38196375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma.
    Liu Y; Zhang Z; Fu S; Wang S; Cheng X; Lei K; Li Z; Sun T; Ma M
    Int J Gen Med; 2021; 14():6741-6754. PubMed ID: 34675634
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ma T; Meng L; Wang X; Tian Z; Wang J; Liu X; Zhang W; Zhang Y
    Am J Transl Res; 2021; 13(10):11048-11064. PubMed ID: 34786042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study.
    Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T
    Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular specificity of lactate metabolism and a novel lactate-related gene pair index for frontline treatment in clear cell renal cell carcinoma.
    Li X; Du G; Li L; Peng K
    Front Oncol; 2023; 13():1253783. PubMed ID: 37795453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers.
    Domingo-Vidal M; Whitaker-Menezes D; Mollaee M; Lin Z; Tuluc M; Philp N; Johnson JM; Zhan T; Curry J; Martinez-Outschoorn U
    Front Oncol; 2022; 12():906494. PubMed ID: 35814364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α Induces HECTD2 Up-Regulation and Aggravates the Malignant Progression of Renal Cell Cancer
    Lv D; Shen T; Yao J; Yang Q; Xiang Y; Ma Z
    Front Cell Dev Biol; 2021; 9():775642. PubMed ID: 35004677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCT1 expression is independently related to shorter cancer-specific survival in clear cell renal cell carcinoma.
    de Carvalho PA; Bonatelli M; Cordeiro MD; Coelho RF; Reis S; Srougi M; Nahas WC; Pinheiro C; Leite KRM
    Carcinogenesis; 2021 Dec; 42(12):1420-1427. PubMed ID: 34668521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
    Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
    PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer.
    Cowman SJ; Fuja DG; Liu XD; Tidwell RSS; Kandula N; Sirohi D; Agarwal AM; Emerson LL; Tripp SR; Mohlman JS; Stonhill M; Garcia G; Conley CJ; Olalde AA; Sargis T; Ramirez-Torres A; Karam JA; Wood CG; Sircar K; Tamboli P; Boucher K; Maughan B; Spike BT; Ho TH; Agarwal N; Jonasch E; Koh MY
    Clin Cancer Res; 2020 Sep; 26(18):4970-4982. PubMed ID: 32586940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.